Haloperidol/quetiapine/risperidoneNeuroleptic malignant syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1823卷 / 1期

关键词：

D O I：

10.1007/s40278-020-83809-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：181 / 181

相关论文

共 50 条

[31] RisperidoneNeuroleptic malignant syndrome: case report
Reactions Weekly, 2009, 1267 (1) : 27 - 27
[32] RisperidoneNeuroleptic malignant syndrome: case report
Reactions Weekly, 2015, 1565 (1) : 214 - 214
[33] RisperidoneNeuroleptic malignant syndrome: case report
Reactions Weekly, 2024, 2028 (1) : 458 - 458
[34] RisperidoneNeuroleptic malignant syndrome: case report
Reactions Weekly, 2014, 1527 (1) : 179 - 179
[35] RisperidoneNeuroleptic malignant syndrome: case report
Reactions Weekly, 2020, 1807 (1) : 172 - 172
[36] RisperidoneNeuroleptic malignant syndrome: case report
Reactions Weekly, 2018, 1717 (1) : 244 - 244
[37] RisperidoneNeuroleptic malignant syndrome: case report
Reactions Weekly, 2013, 1454 (1) : 38 - 38
[38] RisperidoneNeuroleptic malignant syndrome: case report
Reactions Weekly, 2015, 1539 (1) : 254 - 254
[39] Metoclopramide/risperidoneNeuroleptic malignant syndrome: case report
Reactions Weekly, 2019, 1768 (1) : 229 - 229
[40] Loxapine/risperidoneNeuroleptic malignant syndrome: case report
Reactions Weekly, 2021, 1847 (1) : 281 - 281

← 1 2 3 4 5 →